Replies to post #9278 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

I wouldn't be so fast assuming the street is going to look any differently at this transaction.

You are correct that Momenta isn't shackled by it's previous poor contracts but there is a big difference in having a duopoly versus an all out generic where price erosion is the main selling point. Lastly, I certainly think Teva will be a formidable competitor.